Cargando…

Investigation of the Protective Effect for GcMAF by a Glycosidase Inhibitor and the Glycan Structure of Gc Protein

O-linked α-N-acetylgalactosamine (α-GalNAc) in the Gc protein is essential for macrophage activation; thus, the GalNAc-attached form of Gc protein is called Gc macrophage activating factor (GcMAF). O-linked glycans in Gc proteins from human plasma mainly consist of trisaccharides. GcMAF is produced...

Descripción completa

Detalles Bibliográficos
Autores principales: Kanie, Yoshimi, Maegawa, Yuya, Wei, Yi, Kanie, Osamu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9963009/
https://www.ncbi.nlm.nih.gov/pubmed/36838558
http://dx.doi.org/10.3390/molecules28041570
_version_ 1784896144717905920
author Kanie, Yoshimi
Maegawa, Yuya
Wei, Yi
Kanie, Osamu
author_facet Kanie, Yoshimi
Maegawa, Yuya
Wei, Yi
Kanie, Osamu
author_sort Kanie, Yoshimi
collection PubMed
description O-linked α-N-acetylgalactosamine (α-GalNAc) in the Gc protein is essential for macrophage activation; thus, the GalNAc-attached form of Gc protein is called Gc macrophage activating factor (GcMAF). O-linked glycans in Gc proteins from human plasma mainly consist of trisaccharides. GcMAF is produced when glycans on the Gc protein are hydrolyzed by α-Sia-ase and β-Gal-ase, leaving an α-GalNAc. Upon hydrolysis of α-GalNAc present on GcMAF, the protein loses the macrophage-activating effect. In contrast, our synthesized pyrrolidine-type iminocyclitol possessed strong in vitro α-GalNAc-ase inhibitory activity. In this study, we examined the protective effects of iminocyclitol against GcMAF via inhibition of α-GalNAc-ase activity. Detailed mass spectrometric analyses revealed the protective effect of the inhibitor on GcMAF. Furthermore, structural information regarding the glycosylation site and glycan structure was obtained using tandem mass spectrometric (MS/MS) analysis of the glycosylated peptides after tryptic digestion.
format Online
Article
Text
id pubmed-9963009
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-99630092023-02-26 Investigation of the Protective Effect for GcMAF by a Glycosidase Inhibitor and the Glycan Structure of Gc Protein Kanie, Yoshimi Maegawa, Yuya Wei, Yi Kanie, Osamu Molecules Article O-linked α-N-acetylgalactosamine (α-GalNAc) in the Gc protein is essential for macrophage activation; thus, the GalNAc-attached form of Gc protein is called Gc macrophage activating factor (GcMAF). O-linked glycans in Gc proteins from human plasma mainly consist of trisaccharides. GcMAF is produced when glycans on the Gc protein are hydrolyzed by α-Sia-ase and β-Gal-ase, leaving an α-GalNAc. Upon hydrolysis of α-GalNAc present on GcMAF, the protein loses the macrophage-activating effect. In contrast, our synthesized pyrrolidine-type iminocyclitol possessed strong in vitro α-GalNAc-ase inhibitory activity. In this study, we examined the protective effects of iminocyclitol against GcMAF via inhibition of α-GalNAc-ase activity. Detailed mass spectrometric analyses revealed the protective effect of the inhibitor on GcMAF. Furthermore, structural information regarding the glycosylation site and glycan structure was obtained using tandem mass spectrometric (MS/MS) analysis of the glycosylated peptides after tryptic digestion. MDPI 2023-02-06 /pmc/articles/PMC9963009/ /pubmed/36838558 http://dx.doi.org/10.3390/molecules28041570 Text en © 2023 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Article
Kanie, Yoshimi
Maegawa, Yuya
Wei, Yi
Kanie, Osamu
Investigation of the Protective Effect for GcMAF by a Glycosidase Inhibitor and the Glycan Structure of Gc Protein
title Investigation of the Protective Effect for GcMAF by a Glycosidase Inhibitor and the Glycan Structure of Gc Protein
title_full Investigation of the Protective Effect for GcMAF by a Glycosidase Inhibitor and the Glycan Structure of Gc Protein
title_fullStr Investigation of the Protective Effect for GcMAF by a Glycosidase Inhibitor and the Glycan Structure of Gc Protein
title_full_unstemmed Investigation of the Protective Effect for GcMAF by a Glycosidase Inhibitor and the Glycan Structure of Gc Protein
title_short Investigation of the Protective Effect for GcMAF by a Glycosidase Inhibitor and the Glycan Structure of Gc Protein
title_sort investigation of the protective effect for gcmaf by a glycosidase inhibitor and the glycan structure of gc protein
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9963009/
https://www.ncbi.nlm.nih.gov/pubmed/36838558
http://dx.doi.org/10.3390/molecules28041570
work_keys_str_mv AT kanieyoshimi investigationoftheprotectiveeffectforgcmafbyaglycosidaseinhibitorandtheglycanstructureofgcprotein
AT maegawayuya investigationoftheprotectiveeffectforgcmafbyaglycosidaseinhibitorandtheglycanstructureofgcprotein
AT weiyi investigationoftheprotectiveeffectforgcmafbyaglycosidaseinhibitorandtheglycanstructureofgcprotein
AT kanieosamu investigationoftheprotectiveeffectforgcmafbyaglycosidaseinhibitorandtheglycanstructureofgcprotein